Hugo Arasanz: specialist in Medical Oncology, specialized in thoracic oncology and central nervous system tumors, and Doctor of Health Sciences from the Public University of Navarra (2020). He actively participates in clinical trials, some of them as principal investigator, and was coordinator of the FER-FEN-2019-01 trial. In recent years he has participated in different basic/translational research projects with competitive funding, two of them as principal investigator, focused on cancer immunotherapy, biomarker studies, as well as treatment resistance and molecular pathways. He has more than 50 publications in indexed journals, with an h-index of 21.
Imanol Arozarena completed his PhD in Dr. Piero Crespo's laboratory at the University of Cantabria, where he studied the RAS/MAPK pathway. He subsequently, pursued postdoctoral research at the Institute of Cancer Research in London (2006-2009) and at the University of Manchester (2010-2014), where he worked on melanoma skin cancer in the laboratories of Dr. Richard Marais and Dr. Claudia Wellbrock. During this period, Dr. Arozarena focused on the mechanisms of metastatic dissemination and resistance to targeted therapies of tumor cells. After two years working as a professor and Principal Investigator at the University of Huddersfield, he established the Cancer Signaling Unit at Navarrabiomed where he continued his research on melanoma. In the last 8 years he has also developed other research lines focused on brain tumors such as glioblastoma multiforme and metastatic breast cancer. Currently, the Cancer Signaling Unit focuses on investigating the molecular mechanisms and metabolic adaptation that tumor cells develop in response to therapies commonly used in clinical practice such as radiotherapy and immunotherapy.
Prueba tesis en curso
Head of the Geriatrics Department at the University Hospital of Navarra (HUN), Scientific Director of the Navarra Institute for Health Research (IdiSNA), Professor at the Public University of Navarra (UPNA), at the University of Navarra (UNAV) and at the European Academy of Geriatric Medicine (EAMA).
Gradurated in Medicine and Surgery from the University of Navarra (UNAV) in 1996, completed surgical residency training in England (Colchester General Hospital – 1997), specialist in Geriatrics (Getafe University Hospital - 2002) and PhD from UPNA (2008). Postgraduate Expert in Probability and Statistics from UNED, expert in Health Services Research at the University of Alcalá, expert in Promotion and Management of European R&D Projects and expert in Advances in Health Systems Management.
Member of the CIBER of frailty and healthy aging of ISCIII and of the Board of the European Academy of Geriatric Medicine. Spanish representative to the European Union Geriatric Medicine Society and Vice President of the Spanish Society of Geriatrics and Gerontology.
In the field of research, he has authored 214 scientific publications. I have participated in 26 research projects at regional, national and European levels, where we recently led a European project within the SUDOE call. He has participated in more than 40 international conferences and more than 80 national ones that have allowed me to present results of these investigations.
He serves as Editor-in-Chief of the Spanish Journal of Geriatrics and Gerontology (REGG), a consultant and reviewer for various journals at an international level, and an evaluator of national and international Research Projects. I have supervised 8 doctoral theses and I currently have 9 in development.